For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor. Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Scores? T ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens. It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? Developed alo ...

Cencora (COR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system. Since a chan ...

Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $1.1 ... [+] billion, which will be used "primarily for debt paydown and general corporate purposes," the drugstore giant said August 1, 2024 In this photo, a business sign hangs over the entrance to a Walgreens pharmacy and store in Alexandria, Virginia. (Photo by Robert Alexander/Getty Images) Getty Images Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $1.1 billi ...

Cencora (COR) reported $74.24 billion in revenue for the quarter ended June 2024, representing a year-overyear increase of 10.9%. EPS of $3.34 for the same period compares to $2.92 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $73.58 billion, representing a surprise of +0.90%. The company delivered an EPS surprise of +5.03%, with the consensus EPS estimate being $3.18. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how t ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | --- | |-------------------------------------------------------|------------------------------------------------------------------|--------------------------------- ...

Cencora, Inc. (COR) reported third-quarter fiscal 2024 adjusted earnings per share (EPS) of $3.34, which beat the Zacks Consensus Estimate of 3.18 by 5%. The bottom line also improved 14.4% year over year. GAAP EPS was $2.42, up 3% from that reported in the year-ago period. Revenue Details Revenues totaled $74.2 billion, up 10.9% year over year. The top line beat the Zacks Consensus Estimate by 0.8%. Segmental Analysis U.S. Healthcare Solutions Revenues in this segment totaled $67.2 billion, up 12.2% on a y ...

Cencora, Inc. (NYSE:COR) Q3 2024 Earnings Conference Call July 31, 2024 8:30 AM ET Company Participants Bennett Murphy - Senior Vice President, Head of Investor Relations & Treasury Steve Collis - Chairman, President & Chief Executive Officer Bob Mauch - Executive Vice President & Chief Operating Officer Jim Cleary - Executive Vice President & Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Michael Cherny - Leerink Partners Elizabeth Anderson - Evercore ISI Allen Lutz - Bank of Ame ...

• Disability:IN announced that Cencora earned the recognition of a "Best Place to Work for Disability Inclusion" for the second year in a row based on the company's score on the Disability Equality Index. | --- | --- | |-----------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | Financial highlights & fiscal 2024 guidance | | • Adj ...

Cencora (COR) came out with quarterly earnings of $3.34 per share, beating the Zacks Consensus Estimate of $3.18 per share. This compares to earnings of $2.92 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 5.03%. A quarter ago, it was expected that this prescription drug distributor would post earnings of $3.65 per share when it actually produced earnings of $3.80, delivering a surprise of 4.11%. Over the last four quarters, ...